From the Bench, AACR D3 2026: Emerging Therapeutic Strategies to Inhibit KRAS, Enhance ADCs, and Tackle Resistance
The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next...
The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next...
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...